Equities

Aptamer Group PLC

APTA:LSE

Aptamer Group PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)0.2298
  • Today's Change0.0047 / 2.11%
  • Shares traded150.42k
  • 1 Year change-81.62%
  • Beta--
Data delayed at least 20 minutes, as of Nov 01 2024 08:14 BST.
More ▼

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of GBP
(except for per share items)
Fiscal data as of Jun 30 2024202420232022
OPERATIONS
Net income(2.96)(7.84)(2.09)
Depreciation/depletion0.253.400.43
Non-Cash items(0.05)(0.24)(0.02)
Cash taxes paid, supplemental(0.46)(0.53)(0.6)
Cash interest paid, supplemental0.080.140.06
Changes in working capital0.480.61(0.72)
Total cash from operations(2.28)(4.06)(2.38)
INVESTING
Capital expenditures(0.12)(2.03)(0.42)
Other investing and cash flow items, total------
Total cash from investing(0.12)(2.03)(0.42)
FINANCING
Financing cash flow items(0.08)(0.14)(0.06)
Total cash dividends paid------
Issuance (retirement) of stock, net3.490.019.58
Issuance (retirement) of debt, net(0.37)(0.23)(0.41)
Total cash from financing3.04(0.37)9.12
NET CHANGE IN CASH
Foreign exchange effects------
Net change in cash0.64(6.46)6.32
Net cash-begin balance/reserved for future use0.236.690.37
Net cash-end balance/reserved for future use0.870.236.69
SUPPLEMENTAL INCOME
Depreciation, supplemental0.253.400.43
Cash interest paid, supplemental0.080.140.06
Cash taxes paid, supplemental(0.46)(0.53)(0.6)
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.